354 related articles for article (PubMed ID: 23168217)
1. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.
Dubuc V; Moore DF; Gioia LC; Saposnik G; Selchen D; Lanthier S
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1288-92. PubMed ID: 23168217
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.
Rolfs A; Böttcher T; Zschiesche M; Morris P; Winchester B; Bauer P; Walter U; Mix E; Löhr M; Harzer K; Strauss U; Pahnke J; Grossmann A; Benecke R
Lancet; 2005 Nov; 366(9499):1794-6. PubMed ID: 16298216
[TBL] [Abstract][Full Text] [Related]
3. Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke.
Saposnik G; Lanthier S; Mamdani M; Thorpe KE; Melo M; Pope K; Selchen D; Moore DF; ;
Int J Stroke; 2012 Apr; 7(3):265-73. PubMed ID: 22264232
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
[TBL] [Abstract][Full Text] [Related]
5. Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.
Wozniak MA; Kittner SJ; Tuhrim S; Cole JW; Stern B; Dobbins M; Grace ME; Nazarenko I; Dobrovolny R; McDade E; Desnick RJ
Stroke; 2010 Jan; 41(1):78-81. PubMed ID: 20007919
[TBL] [Abstract][Full Text] [Related]
6. Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine.
Kinoshita N; Hosomi N; Matsushima H; Nakamori M; Yagita Y; Yamawaki T; Torii T; Kitamura T; Sueda Y; Shimomura R; Araki M; Nezu T; Aoki S; Ishii S; Maruyama H; Matsumoto M; Maruyama H
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3563-3569. PubMed ID: 30201457
[TBL] [Abstract][Full Text] [Related]
7. Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.
Brouns R; Sheorajpanday R; Braxel E; Eyskens F; Baker R; Hughes D; Mehta A; Timmerman T; Vincent MF; De Deyn PP
Clin Neurol Neurosurg; 2007 Jul; 109(6):479-84. PubMed ID: 17509753
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.
Lanthier S; Saposnik G; Lebovic G; Pope K; Selchen D; Moore DF;
Stroke; 2017 Jul; 48(7):1766-1772. PubMed ID: 28596458
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients.
Baptista MV; Ferreira S; Pinho-E-Melo T; Carvalho M; Cruz VT; Carmona C; Silva FA; Tuna A; Rodrigues M; Ferreira C; Pinto AA; Leitão A; Gabriel JP; Calado S; Oliveira JP; Ferro JM;
Stroke; 2010 Mar; 41(3):431-6. PubMed ID: 20110537
[TBL] [Abstract][Full Text] [Related]
10. Screening for Fabry's disease in young patients with ischemic stroke in a Chinese population.
Song X; Xue S; Zhao J; Wu J
Int J Neurosci; 2017 Apr; 127(4):350-355. PubMed ID: 26981927
[TBL] [Abstract][Full Text] [Related]
11. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease.
Brouns R; Thijs V; Eyskens F; Van den Broeck M; Belachew S; Van Broeckhoven C; Redondo P; Hemelsoet D; Fumal A; Jeangette S; Verslegers W; Baker R; Hughes D; De Deyn PP;
Stroke; 2010 May; 41(5):863-8. PubMed ID: 20360539
[TBL] [Abstract][Full Text] [Related]
12. The Frequency of Fabry Disease among Young Cryptogenic Stroke Patients in the City of Sakarya.
Gündoğdu AA; Kotan D; Alemdar M
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1334-1340. PubMed ID: 28283366
[TBL] [Abstract][Full Text] [Related]
13. Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.
Sarikaya H; Yilmaz M; Michael N; Miserez AR; Steinmann B; Baumgartner RW
Eur J Neurol; 2012 Nov; 19(11):1421-6. PubMed ID: 22680335
[TBL] [Abstract][Full Text] [Related]
14. De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.
Romani I; Borsini W; Nencini P; Morrone A; Ferri L; Frusconi S; Donadio VA; Liguori R; Donati MA; Falconi S; Pracucci G; Inzitari D
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2588-95. PubMed ID: 26298600
[TBL] [Abstract][Full Text] [Related]
15. An intronic haplotype in α galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke.
Zeevi DA; Hakam-Spector E; Herskovitz Y; Beeri R; Elstein D; Altarescu G
Gene; 2014 Oct; 549(2):275-9. PubMed ID: 25101867
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Fabry Disease in Young Patients with Stroke in Argentina.
Reisin RC; Mazziotti J; Cejas LL; Zinnerman A; Bonardo P; Pardal MF; Martínez A; Riccio P; Ameriso S; Bendersky E; Nofal P; Cairola P; Jure L; Sotelo A; Rozenfeld P; Ceci R; Casas-Parera I; Sánchez-Luceros A;
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):575-582. PubMed ID: 29132836
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry.
Romani I; Sarti C; Nencini P; Pracucci G; Zedde M; Cianci V; Nucera A; Moller J; Orsucci D; Toni D; Palumbo P; Casella C; Pinto V; Barbarini L; Bella R; Scoditti U; Ragno M; Mezzapesa DM; Tassi R; Volpi G; Diomedi M; Bigliardi G; Cavallini AM; Chiti A; Ricci S; Cecconi E; Linoli G; Sacco S; Rasura M; Giordano A; Bonetti B; Melis M; Cariddi LP; Dossi RC; Grisendi I; Aguglia U; Di Ruzza MR; Melis M; Sbardella E; Vista M; Valenti R; Musolino RF; Passarella B; Direnzo V; Pennisi G; Genovese A; Di Marzio F; Sgobio R; Acampa M; Nannucci S; Dagostino F; Dell'Acqua ML; Cuzzoni MG; Picchioni A; Calchetti B; Notturno F; Di Lisi F; Forlivesi S; Delodovici ML; Buechner SC; Biagini S; Accavone D; Manna R; Morrone A; Inzitari D
J Neurol Sci; 2024 Feb; 457():122905. PubMed ID: 38295534
[TBL] [Abstract][Full Text] [Related]
19. Nationwide screening for Fabry disease in unselected stroke patients.
Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
[TBL] [Abstract][Full Text] [Related]
20. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
